Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock

<h4>Background</h4> Vasoactive treatment is a cornerstone in treating hypoperfusion in cardiogenic shock following acute myocardial infarction (AMICS). The purpose was to compare the achievement of treatment targets and outcome in relation to vasoactive strategy in AMICS patients stratif...

Full description

Bibliographic Details
Main Authors:	Nanna Louise Junker Udesen, Ole Kristian Lerche Helgestad, Jakob Josiassen, Christian Hassager, Henrik Frederiksen Højgaard, Louise Linde, Jesper Kjaergaard, Lene Holmvang, Lisette Okkels Jensen, Henrik Schmidt, Hanne Berg Ravn, Jacob Eifer Møller
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352108/?tool=EBI

Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock. by Nanna Louise Junker Udesen, Ole Kristian Lerche Helgestad, Jakob Josiassen, Christian Hassager, Henrik Frederiksen Højgaard, Louise Linde, Jesper Kjaergaard, Lene Holmvang, Lisette Okkels Jensen, Henrik Schmidt, Hanne Berg Ravn, Jacob Eifer Møller

Published 2022-01-01

Get full text

Article

Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock

Similar Items